Cost-effectiveness of Osteoporosis Screening in Women over 40 Years old

Abstract:     Introduction: Osteoporosis is a disease recognized by bone density reduction, and is particularly common among older women which impose them to fractures. The evidence shows that if do not serious conflict with this issue, in the far little future, huge costs will be imposed o...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Nahid Hatam, fereshte keshavarzi, elham Aflaki, mehrdad askarian
Formato: article
Lenguaje:EN
Publicado: Tehran University of Medical Sciences 2021
Materias:
Acceso en línea:https://doaj.org/article/23e2b42f420140bfb18c4ef8b286e5b7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:23e2b42f420140bfb18c4ef8b286e5b7
record_format dspace
spelling oai:doaj.org-article:23e2b42f420140bfb18c4ef8b286e5b72021-11-29T06:16:20ZCost-effectiveness of Osteoporosis Screening in Women over 40 Years old0044-60251735-969410.18502/acta.v59i11.7777https://doaj.org/article/23e2b42f420140bfb18c4ef8b286e5b72021-11-01T00:00:00Zhttps://acta.tums.ac.ir/index.php/acta/article/view/8516https://doaj.org/toc/0044-6025https://doaj.org/toc/1735-9694Abstract:     Introduction: Osteoporosis is a disease recognized by bone density reduction, and is particularly common among older women which impose them to fractures. The evidence shows that if do not serious conflict with this issue, in the far little future, huge costs will be imposed on individuals, families and the country. In this study we studied the cost-effectiveness of osteoporosis screening in women over 40 years of age in Shiraz in 2016.   Methods: This cross-sectional study was performed on 240 persons who were screened and 240 non-screened persons in bone mineral density ward of Shiraz Namazi Hospital. The costs were identified and from the perspective of the insurer and the payer, which included only direct health care costs. To measure the effectiveness, use of indicators as quality-adjusted life-years (QALY), the expected cost and effectiveness, and the Incremental cost-effectiveness ratio were calculated. Results: The results showed that non screening is the best strategy. Given that the amount of ICER was obtained at $38484.56 and the threshold. As a result, the non screening method compared to screening is cost-effectiveness. Conclusion: The relevant authorities and proficients should prevent the progression of disease complications and consequently prevent the increase of the disease cost and improving the quality of life of the patients.Nahid Hatamfereshte keshavarzielham Aflakimehrdad askarianTehran University of Medical Sciencesarticleosteoporosiscost-effectivenessscreening.Medicine (General)R5-920ENActa Medica Iranica, Pp 649-655 (2021)
institution DOAJ
collection DOAJ
language EN
topic osteoporosis
cost-effectiveness
screening.
Medicine (General)
R5-920
spellingShingle osteoporosis
cost-effectiveness
screening.
Medicine (General)
R5-920
Nahid Hatam
fereshte keshavarzi
elham Aflaki
mehrdad askarian
Cost-effectiveness of Osteoporosis Screening in Women over 40 Years old
description Abstract:     Introduction: Osteoporosis is a disease recognized by bone density reduction, and is particularly common among older women which impose them to fractures. The evidence shows that if do not serious conflict with this issue, in the far little future, huge costs will be imposed on individuals, families and the country. In this study we studied the cost-effectiveness of osteoporosis screening in women over 40 years of age in Shiraz in 2016.   Methods: This cross-sectional study was performed on 240 persons who were screened and 240 non-screened persons in bone mineral density ward of Shiraz Namazi Hospital. The costs were identified and from the perspective of the insurer and the payer, which included only direct health care costs. To measure the effectiveness, use of indicators as quality-adjusted life-years (QALY), the expected cost and effectiveness, and the Incremental cost-effectiveness ratio were calculated. Results: The results showed that non screening is the best strategy. Given that the amount of ICER was obtained at $38484.56 and the threshold. As a result, the non screening method compared to screening is cost-effectiveness. Conclusion: The relevant authorities and proficients should prevent the progression of disease complications and consequently prevent the increase of the disease cost and improving the quality of life of the patients.
format article
author Nahid Hatam
fereshte keshavarzi
elham Aflaki
mehrdad askarian
author_facet Nahid Hatam
fereshte keshavarzi
elham Aflaki
mehrdad askarian
author_sort Nahid Hatam
title Cost-effectiveness of Osteoporosis Screening in Women over 40 Years old
title_short Cost-effectiveness of Osteoporosis Screening in Women over 40 Years old
title_full Cost-effectiveness of Osteoporosis Screening in Women over 40 Years old
title_fullStr Cost-effectiveness of Osteoporosis Screening in Women over 40 Years old
title_full_unstemmed Cost-effectiveness of Osteoporosis Screening in Women over 40 Years old
title_sort cost-effectiveness of osteoporosis screening in women over 40 years old
publisher Tehran University of Medical Sciences
publishDate 2021
url https://doaj.org/article/23e2b42f420140bfb18c4ef8b286e5b7
work_keys_str_mv AT nahidhatam costeffectivenessofosteoporosisscreeninginwomenover40yearsold
AT fereshtekeshavarzi costeffectivenessofosteoporosisscreeninginwomenover40yearsold
AT elhamaflaki costeffectivenessofosteoporosisscreeninginwomenover40yearsold
AT mehrdadaskarian costeffectivenessofosteoporosisscreeninginwomenover40yearsold
_version_ 1718407574566469632